This training course has been postponed to the New Year. To make an enquiry please contact training@onenucleus.com. The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely: Drug Discovery Biology, ADMET/PK/PD, Medicinal Chemistry, Informatics/Virtual technologies and how these contributions are phased over time and integrated to generate a drug suitable for clinical trial. Online 2 day training course made up of 4 sessions.
| Audience | Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers and general managers. |
| Duration | A one day course. |
| Objectives | The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely: Drug Discovery Biology, ADMET/PK/PD, Medicinal Chemistry, Informatics/Virtual technologies and how these contributions are phased over time and integrated to generate a drug suitable for clinical trials.
The focus is on small molecule drugs with comparisons made with biologics. Based on real-world experience and practical realities, attendees travel step-by-step along a typical drug discovery path, namely: Initiating Idea -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination.
Essential related topics include drug discovery technology platforms, drug structural-functional quality attributes and Project management tools, namely Target Product Profile (TPP) use.
Key technology and infrastructure requirements are also covered in the course. |
|
| Costs | Gold Members: £357+ VAT
Silver Members: £433.50 + VAT
Non-members: £510 + VAT |
You will receive webinar details closer to the time.
To make an enquiry please contact training@onenucleus.com.
